semaglutide consent form pdf free download Ozempic Questionnaire: Patient Screening Guide - Semaglutide Weight Loss Dosage Chart

Semaglutide does not promote rapid weight loss, which leads to adverse effects in the long run

Compounded medications, lacking rigorous FDA oversight, do not align with our strict standards

Lowering carb intake helps stabilize blood sugar and reduces water retention

In a large study published in the New England Journal of Medicine, Semaglutide (which is the active ingredient in both Ozempic) led to an average weight loss of about 15% of the body weight in about a year, which is an average total weight loss of about 33.7 lbs

After propensity score matching (18,386 patients), researchers found: Patients receiving tirzepatide were 1.76 times more likely to achieve 5% weight loss 2.54 times more likely to achieve 10% weight loss 3.24 times more likely to achieve 15% weight loss At 12 months, the difference in weight change was 6.9 percentage points favoring tirzepatide

Further exploration of doseresponse relationships, long-term maintenance strategies, and the potential preventive role of GLP-1 RAs in high-risk populations (e.g., insulin-resistant youth with depressive symptoms) will be key to translating preliminary findings into clinical practice